Brief: Merus Q3 Net Income USD -23.012 Million
02/11/2023 20:13
Nov 02 (Reuters) - Merus Q3 operating income USD -38.368 million. * Q3 collaboration revenue USD 11.033 million * Q3 pretax profit USD -21.894 million * Q3 operating expenses USD 49.401 million
Recent news on Merus NV
See all newsNASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Merus And Halozyme enter global collaboration and license agreement to develop subcutaneous formulation Of Petosemtamab